{"nct_id":"NCT04567615","title":"A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-02-04","start_date_type":"ACTUAL","primary_completion_date":"2023-08-31","primary_completion_date_type":"ACTUAL","completion_date":"2025-10-03","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BMY"]}